Related Experiment Video
Updated: Jul 16, 2026
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
[Gene therapy strategies for colorectal cancer]
1National Centre for Biomedical Engineering Science, National University of Ireland, Galway.
Abstract:
Current advances in CRC treatment have led to significant but slight improvements in patient survival with curative outcomes only seen in earlier stage cancers. Consequently, much effort is being put into developing completely novel therapies that fulfil a number of criteria including greater efficacy and fewer side effects. Many of these conditions are met by the wide range of gene therapy strategies currently in pre-clinical or clinical trial phases. Gene therapy approaches may be broadly broken down into three main areas: Following a few tragic events in the context of clinical gene therapy studies, safety is currently the prime concern. Further progress in the field is expected from the combination of the described approaches with conventional treatment modalities.
Insights
Novel gene therapies offer improved efficacy and fewer side effects for colorectal cancer (CRC) treatment, addressing limitations of current therapies. Safety remains a key concern, with combined approaches showing promise for future progress.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Context:
- Colorectal cancer (CRC) treatment advances yield modest survival improvements, primarily in early stages.
- Curative outcomes remain elusive for advanced-stage CRC.
- Significant unmet needs exist for more effective and safer cancer therapies.
Purpose:
- To explore novel gene therapy strategies for colorectal cancer.
- To evaluate the potential of gene therapy in addressing current treatment limitations.
- To highlight safety considerations and future directions in gene therapy for CRC.
Summary:
- Gene therapy presents a promising avenue for CRC treatment, offering potentially greater efficacy and reduced side effects compared to conventional methods.
- Current gene therapy approaches for CRC are in pre-clinical and clinical trial phases, broadly categorized into distinct strategies.
- Safety is a paramount concern in clinical gene therapy, necessitating careful consideration and rigorous evaluation.
Impact:
- Gene therapy holds the potential to revolutionize colorectal cancer treatment paradigms.
- Advancements in gene therapy could lead to improved patient survival rates and quality of life.
- Future progress is anticipated through the integration of gene therapy with established treatment modalities.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...